In today’s recent session, 2.18 million shares of the Regencell Bioscience Holdings Ltd (NASDAQ:RGC) have been traded, and its beta is -0.58. Most recently the company’s share price was $6.74, and it changed around $2.09 or 44.95% from the last close, which brings the market valuation of the company to $87.69M. RGC at last check was trading at a discount to its 52-week high of $32.44, offering almost -381.31% off that amount. The share price’s 52-week low was $3.03, which indicates that the recent value has risen by an impressive 55.04% since then. We note from Regencell Bioscience Holdings Ltd’s average daily trading volume that its 10-day average is 21600.0 shares, with the 3-month average coming to 165.28K.

Regencell Bioscience Holdings Ltd (NASDAQ:RGC) trade information

Instantly RGC has been showing a green trend so far today with a performance of 44.95% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 12.50 on recent trading dayincreased the stock’s daily price by 46.08%. The company’s shares are currently down -35.81% year-to-date, but still up 34.80% over the last five days. On the other hand, Regencell Bioscience Holdings Ltd (NASDAQ:RGC) is 21.66% up in the 30-day period. We can see from the shorts that 37382.0 shares have been sold at a short interest cover period of 0.36 day(s).

Regencell Bioscience Holdings Ltd (NASDAQ:RGC)’s Major holders

BLACKROCK INC., with 0.0018% or 238.0 shares worth $800.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.